Venous Forum annual spring meeting
Wednesday - Thursday 25 - 26 April 2012
Venue: Royal Society of Medicine, 1 Wimpole Street, LONDON, W1G 0AE
We are no longer accepting registrations for this meeting via the website. If you would like to attend this meeting, please contact Beilul Kahsai directly on 020 7290 3859.
Registration Details:
RSM Fellow - 2 days: £245
RSM Trainee - 2 days: £110
RSM Student - 2 days: £75
BAS Member - 2 days: £245
BAS Member: £150
Consultant/GP - 2 days: £300
Trainee - 2 days: £160
AHP/Nurse/Midwife - 2 days: £110
Student - 2 days: £110
Consultant/GP: £170
RSM Student: £50
RSM Trainee: £70
RSM Associate: £20
RSM Fellow: £150
Student: £70
Trainee: £90
AHP/Nurse/Midwife: £70
Catering invoice for free stands: £60
Dinner: £50
Wednesday 25 April - DAY 1 |
|
9.30 am |
Registration with refreshments |
9.55 am |
Welcome |
| Professor Andrew Bradbury, President of the Venous Forum, Royal Society of Medicine | |
|
Symposium 1: VTE - Epidemiology, NHS strategy and guidelines |
|
10.00 am |
Epidemiology of VTE, risk factors and sequelae |
| Dr Ander Cohen, Honorary Consultant Vascular Physician, King's College Hospital and Founder of the Coalition to Prevent VTE, London, UK | |
10.15 am |
A VTE strategy for the NHS |
| Dr Mike Durkin, National Clinical Director for Venous Thrombo-Embolism | |
10.30 am |
VTE rates after hospital admissions in England - how are vascular specialists performing? |
| Dr Will Lester, Consultant Haematologist, University Hospitals Birmingham NHS Foundation Trust, UK | |
11.45 am |
VTE guidelines: past, present and future |
| Professor Gerry Stansby, Professor of Vascular Surgery, University of Newcastle, and Chair, NICE VTE Guideline Development Group | |
11.00 am |
Panel discussion |
| All speakers | |
11.15 am |
Break |
| Visit trade exhibition and poster presentations | |
|
Invited Lecture |
|
11.40 am |
New oral anticoagulants in the prevention and management of venous thrombo-embolism (VTE) |
| Professor Andrew Nicolaides, Professor of Vascular Surgery, Vascular Screening and Diagnostic Centre, London and Cyprus | |
11.55 am |
Questions |
|
Free paper session 1 |
|
12.00 pm |
6 free papers |
1.00 pm |
Lunch |
| Visit trade exhibition and poster presentations | |
|
Venous forum pump priming grant 2011 report |
|
2.00 pm |
A study to develop a percutaneous vein valve implant for the treatment of deep venous disease |
| Ms Hayley Moore, Imperial College London | |
|
Symposium 2: VTE - Diagnosis and treatment |
|
2.10 pm |
How can we best confidently diagnose, or alternatively exclude, lower limb DVT? |
| Dr David Keeling, Consultant Haematologist, Oxford Haemophilia and Thrombosis Centre, Oxford University Hospitals NHS Trust | |
2.25 pm |
For how long should we anticoagulate patients after first and recurrent DVT? |
| Dr Patrick Kesteven, Consultant Haematologist, Newcastle Upon Tyne NHS Foundation Trust, UK | |
2.40 pm |
Delivering a high quality service - what is the role of the vascular surgeon? |
| Dr Roopen Arya, Director, Thrombosis Centre, Kings College Hospital and Lead, NHS VTE Exemplar Centre | |
2.55 pm |
Panel discussion |
| All speakers | |
|
Venous Forum Travelling Fellowship 2011 report |
|
|
3.05 pm |
Mr Ankur Thapar, Imperial College London |
3.15 pm |
Break |
| Visit trade exhibition and poster presentations | |
|
The Phlebology RSM Press lecture 2012 |
|
3.45 pm |
Genetics, female hormones and VTE |
| Professor Saskia Middeldorp, Department of Vascular Medicine, Academic Medical Centre, Amsterdam, The Netherlands | |
4.10 pm |
Questions |
|
Symposium 3: VTE - Special patient groups |
|
4.15 pm |
The paediatric patient |
| Professor Alun Davies, Professor of Vascular Surgery, Charing Cross Hospital, Imperial College, London, UK | |
4.25 pm |
The patient with heparin induced thrombocytopenia |
| Professor Mike Laffan, Professor of Haemostasis and Thrombosis, Hammersmith Hospital, Imperial College, London | |
4.35 pm |
The pregnant patient |
| Dr Karen Breen, Thrombosis & Haemostasis, Guy's and St Thomas' NHS Foundation Trust, London, UK | |
4.45 pm |
The patient with cancer |
| Mr David Berridge, Consultant Vascular Surgeon, Leeds, UK | |
4.55 pm |
Panel discussion |
| All speakers | |
|
Business meeting |
|
5.15 pm |
Business meeting and completion of evaluation forms |
5.30 pm |
Close of meeting |
7.30 pm |
Dinner - RSM |
| For those who have pre-booked only | |
Thursday 26 April 2012 - DAY 2 |
|
8.30 am |
Registration with refreshments |
|
Symposium 4: British Association Of Sclerotherapy (BAS) session |
|
9.00 am |
Welcome |
| Mr Philip Coleridge-Smith, President, BAS | |
9.00 am |
Neurological complications following foam sclerotherapy |
| Dr Jean-Luc (J-L) Gillet, President of the French Society of Phlebology | |
9.10 am |
Randomised controlled trial of foam sclerotherapy versus surgery |
| Dr Nadia Shadid, Department of Dermatology, University Medical Centre, Maastricht, The Netherlands | |
9.20 am |
Randomised clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins. |
| Dr Lars Rasmussen, Danish Vein Centres, Eskadronsvej 4A, 4700 Naestved, Denmark | |
9.30 am |
Tessari foam: regulatory issues |
| Dr Mike Watkins, STD Pharmaceuticals, Hereford | |
9.40 am |
Panel discussion |
| All speakers | |
9.55 am |
Focus on technique: how I do ultrasound guided foam sclerotherapy (7 minute presentations) |
| Mr Philip Coleridge-Smith | |
|
10.02 am |
Dr Jean-Luc (J-L) Gillet |
|
10.09 am |
Dr Lars Rasmussen |
|
10.16 am |
Dr Nadia Shadid |
|
10.23 am |
Dr Steve Tristram |
10.30 am |
Panel discussion |
| All speakers | |
10.45 am |
Break |
| Visit trade exhibition and poster presentations | |
|
American College of Phlebology Guest Lecture |
|
11.10 pm |
Compression in mixed ulcers increases arterial inflow and venous output |
| Dr Giovanni Mosti, Barbantini Hospital, Lucca, Italy | |
11.25 pm |
Questions |
|
Free paper session 2 |
|
11.30 am |
6 free papers |
12.30 pm |
Lunch |
| Visit trade exhibition and poster presentations | |
|
Symposium 5: Sponsored by Bayer, Covidien and Medi UK |
|
1.30 pm |
Methods of VTE treatment |
| Dr John Luckit, Consultant Haematologist, North Middlesex University Hospital NHS Trust, UK | |
1.45 pm |
Is RF the new gold standard for venous ablation? |
| Mr Ian Loftus, Consultant Vascular & Endovascular Surgeon, St Georges Hospital, London, UK | |
2.00 pm |
RAL Compression Hosiery - making a difference |
| Mr Kevin Conway, Consultant Vascular & Endovascular Surgeon, Cwm Taf Health Board, Royal Glamorgan Hospital, UK | |
|
Symposium 6: VTE - Prevention of the post-thrombotic syndrome |
|
2.15 pm |
Does extended anticoagulation help prevent the post-thrombotic syndrome? |
| Dr Trevor Baglin, Consultant Haematologist, Addenbrookes NHS Trust, Cambridge | |
2.30 pm |
Does catheter directed and pharmacomechanical thrombolysis help prevent the post-thrombotic syndrome |
| Mr Isaac Nyamekye, Treasurer, Venous Forum, RSM | |
2.45 pm |
What evidence do we need before active intervention (thrombolysis) becomes 'standard of care' for patients with proximal lower limb DVT in the UK - and how do we get that evidence? |
| Professor Alun Davies, Professor of Vascular Surgery, Charing Cross Hospital, Imperial College, London, UK | |
3.00 pm |
Panel discussion |
| All speakers | |
|
Symposium 7: VTE prophylaxis in patients undergoing venous interventions |
|
|
DEBATE: "This House believes that DVT prophylaxis for patients undergoing day case interventions for varicose veins is unnecessary" |
|
|
Pre-debate vote (interactive voting system) |
|
3.15 am |
For the motion: |
| Mr Douglas McWhinnie, Clinical Director - Surgery and Consultant Surgeon, Milton Keynes General Hospital, Milton Keynes, UK and President, British Association of Day Surgery | |
3.25 pm |
Against the motion: |
| Professor Julie Brittenden, Professor of Vascular Surgery, University of Aberdeen, Scotland, UK | |
3.35 pm |
Post-debate vote |
3.40 pm |
Awarding of prizes |
3.45 pm |
Completion of evaluation forms |
3.50 pm |
Close of meeting |
|
Meeting ref: VEC02 CPD (Applied for) |
|